A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration
Status:
Completed
Trial end date:
2016-10-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of intravitreal (IVT)
administration of DE-120 in subjects with treatment-naive active subfoveal choroidal
neovascularization (CNV) secondary to age-related macular degeneration (AMD).